Monday, October 2, 2023
Monday, October 2, 2023

Contact: 561.316.3330

SEIU Reports Workers at 11 Tenet Healthcare Hospitals Across California Overwhelmingly Vote to Strike, Calling for Contract to Address Pandemic Safety

October 27, 2020

SEIU reports Workers at 11 Tenet Healthcare hospitals in California have voted overwhelmingly to go on strike to demand that the giant hospital chain bargain in good faith with employees over health, safety, and other working conditions in their facilities, as caregivers continue to risk their lives caring for patients with COVID-19.

SEIU notes the strike vote covers 4,300 workers at the 11 facilities who are members of SEIU-United Healthcare Workers West. The vote margin was 96 percent in favor of the strike.

Tenet has rejected most of the workers’ proposals on pandemic safety. Workers are asking Tenet to go beyond the minimal federal guidelines to make sure the most comprehensive protections are in place.

“We are scared to come to work knowing we are at great risk of exposure to COVID-19,” said Gisella Thomas, a respiratory therapist at Desert Regional Medical Center in Palm Springs. “We want to work with management at our hospitals to increase protections for our health, our patients’ health, our families’ health, and the health of our communities. We have put forth a pandemic safety proposal that addresses issues workers are concerned about, like staffing, PPE, and increased COVID-19 testing for employees.”

Tenet has made more than $1 billion in profits in the first three quarters of 2020 and received more than $250 million in taxpayer bailout money in California alone. Tenet’s Chief Executive Officer Ron Rittenmeyer was paid more than $24 million in 2019, and the chain’s president and chief operating officer Saum Sutaria was paid nearly $14 million.

“We are calling on Tenet to increase its investment in worker safety and staffing in the middle of the worst pandemic in over a century – to ensure the safety of healthcare workers, our patients, and our entire communities.”

The strike will occur at the following Tenet hospitals in California:

INDIO: John F. Kennedy Memorial Hospital
JOSHUA TREE: High Desert Medical Center
LAKEWOOD: Lakewood Regional Medical Center
LOS ALAMITOS: Los Alamitos Medical Center
MANTECA: Doctors Hospital of Manteca
MODESTO: Doctors Medical Center
PALM SPRINGS: Desert Regional Medical Center
SAN LUIS OBISPO: Sierra Vista Regional Medical Center
SAN RAMON: San Ramon Regional Medical Center
TEMPLETON: Twin Cities Community Hospital
TURLOCK: Emanuel Medical Center

 

SourceSEIU
Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

4SC Receives Orphan Drug Designation (ODD) for resminostat (Kinselby) in CTCL from the US FDA

Jason Loveridge, Ph.D., CEO of 4SC, commented: “Receiving orphan drug designation for resminostat provides us with a number of important benefits, most crucially 7 years’ market exclusivity in the US, a key foundation of our efforts to commercialise Kinselby.  We are currently preparing a marketing authorisation application for Kinselby in the EU, which remains on track for submission in Q1 2024.”

Abyrx Receives FDA Clearance for MONTAGE ® Settable Bone Putty for Use in Cardiothoracic Surgery

By expanding the range of FDA-cleared surgical applications for MONTAGE, this latest milestone positions Abyrx to build upon the more than 25,000 units of MONTAGE that have been used to date by surgeons in trauma, orthopedics, sports medicine, foot and ankle, and craniomaxillofacial procedures.

FDA Grants Fast Track Designation to 9MW3011

9MW3011 has been approved to clinical study by NMPA and FDA, respectively. The first person has been dosed in the clinical study in China in March, 2023.

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

"We are pleased to gain the QIDP and Fast Track designations for DFI as recognition that contezolid and contezolid acefosamil are novel new agents to meet an important unmet need in this common and challenging infection", stated Dr Zhengyu Yuan, Chief Executive Officer at MicuRx. 

Via Nova Therapeutics Announces FDA clearance of Investigational New Drug (IND) Application for VNT-101

"We look forward to evaluating VNT-101 in the clinic," said Don Ganem MD, Co-Founder and CEO of Via Nova Therapeutics. "This is an important step to developing a flu antiviral with a novel mechanism of action, and a milestone for Via Nova Therapeutics as we advance our first compound into the clinic."

By using this website you agree to accept Medical Device News Magazine Privacy Policy